1) Travis WD, et al: An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188: 733-748, 2013.
2) Raghu G, et al: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366: 1968-1977, 2012.
3) Guenther A, et al: The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res 19: 141, 2018.
4) Dempsey TM, et al: Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 200: 168-174, 2019.
5) Flaherty KR, et al: Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381: 1718-1727, 2019.